CHINA PHARMA HOLDINGS, INC. (CPHI) › Net IncomeCHINA PHARMA HOLDINGS, INC. (CPHI) — Net IncomeAnnual figures by fiscal year, from SEC filings.2010: $23.41M2011: $19.27M2012: $4.62M2013: -$20.01M2014: -$39.55M2015: -$15.41M2016: -$9.18M2017: -$19.28M2018: -$10.75M2019: -$20.70M2020: -$2.87M2021: -$3.40M2022: -$3.97M2023: -$3.08M2024: -$4.74M2025: -$3.19M-$3.19M2010Net Income (USD)2025Fiscal YearNet IncomeChange YoY2025-$3.19M+32.7%2024-$4.74M-53.8%2023-$3.08M+22.5%2022-$3.97M-16.9%2021-$3.40M-18.6%2020-$2.87M+86.2%2019-$20.70M-92.6%2018-$10.75M+44.2%2017-$19.28M-109.9%2016-$9.18M+40.4%2015-$15.41M+61.0%2014-$39.55M-97.7%2013-$20.01M-533.3%2012$4.62M-76.0%2011$19.27M-17.7%2010$23.41M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share